I have to go with what we know at this point.
In the firm commitmant there is no provision stated for managment other than a ceiling of 250K$ per year salery from LTC to any officers of LTC. Better than "welcome to walmart" income but a ways from realizing 15 years of work, time and personel investment by managment to get here today. So Ctum looks like their vehical to wealth. I'll follow them.
As far as debt, in no way do I believe LTC will remain a debt free co.. Leverage calls for debt, and qualifying for revolving lines of credit requires paying off debt. Both companies will do that.
Without a known IPO share structure we truley cannot even see our way to being able to proviso accurately splitting between the two, Ctum and LTC. Kinda makes it hard to go 50/50. I take it with a large grain of salt the info Wallstreetman was given as far as getting a true discount with 100k$ via pre IPO prices. Been around tooooo many salesmen and IPO's to not see that mentioned offer as any more than a closing tool. Can it (IPO) be under suscribed, over suscribed and price flucuate 15%? Absolutley! And underwriters will put a positive spin on that I'm sure.
So with what I know, the VC people believe, Managment quotes,
Doctors say, as things move along I expect a runup on Ctum
next year up to maybe 10.00. During that time, it would be a great time for minor dilution with a stock instrument for CTUM
and create a debt free, or most, co. with great income. PPS should not be affected much at all. Course that means our CEO
would have to change his spots, so to speak, but that would be the prime and only time I think he would.
Finally either Co. may be the one to expand first beyond just the original LTC equipment. Say the purchase of an Endoscope mfg. or a new venture soley under CTUM. My feelings are CTUM wins in that case or wins bigtime.
All in my own opinion. and based on what we know.
